Elevated plasma level of differentiation inhibitory factor nm23-H1 protein correlates with risk factors for myelodysplastic syndrome

Leukemia

Volumn 16, Issue 2, 2002, Pages 165-169

  Ito, Y ^a   Okabe Kado, J ^b   Honma, Y ^b   Iwase, O ^a   Shimamoto, T ^a   Ohyashiki, J H ^a   Ohyashiki, K ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

Author keywords

Aplastic anemia; Differentiation inhibitory factor; Myelodysplastic syndrome; nm23; Refractory anemia

Indexed keywords

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; ANEMIA, REFRACTORY; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; MYELODYSPLASTIC SYNDROMES; NUCLEOSIDE-DIPHOSPHATE KINASE; PRELEUKEMIA; PROGNOSIS; RISK FACTORS; TRANSCRIPTION FACTORS;

LEUKEMIA INHIBITORY FACTOR; NUCLEOSIDE DIPHOSPHATE KINASE A; UNCLASSIFIED DRUG;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BLAST TRANSFORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REFRACTORY ANEMIA; RISK ASSESSMENT; SCORING SYSTEM; TUMOR DIFFERENTIATION;

EID: 0036169129     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402370     Document Type: Article

References (31)

1. Myelodysplastic syndrome
2. Proposals for the classification of the myelodysplastic syndromes
3. Decline in antibiotic enzyme activity in neutrophils is a prognostic factor for infections in patients with myelodysplastic syndrome
4. Superoxide anion production and expression of cytochrome b558 by neutrophils are impaired in some patients with myelodysplastic syndrome
5. Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?
6. Long-term follow-up of aplastic anemia
7. Significance of electron-dense deposits in the mitochondrial matrix of erythroid precursors in aplastic anaemia and myelodysplastic syndrome
8. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens
9. Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia
10. Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase
11. Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells
12. Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia
13. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukemia
14. Differentiation inhibitory factor nm23 as a prognostic factor for acute myeloid leukemia
15. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogeneous leukemia and application to other hematologic malignancies
16. Factors inhibiting differentiation of myeloid leukemia cells
17. Evidence for a novel gene associated with low tumor metastatic potential
18. Nm23/nucleoside diphosphate kinase: Toward a structural and biochemical understanding of its biological functions
19. Identification of a second human nm23 gene, nm23-H2
20. Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells
21. nm23-H4, a new member of the family of human nm23/nucleoside diphosphate kinase genes localised on chromosome 16p13
22. A new human nm23 homologue (nm23-H5) specifically expressed in testis germinal cells
23. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme
24. Isolation of human nm23 genomes and analysis of loss of heterozygosity in primary colorectal carcinomas using a specific genomic probe
25. Decrease in nucleoside diphosphate kinase (NDPK/nm23) expression during hematopoietic maturation
26. Prognostic implications of differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma
27. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia
28. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia
29. Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults
30. Human nm23-H1 and H2 proteins have similar nucleoside diphosphate kinase activities
31. Transferrin binding to K562 cell line